Moreover, studies on the immunopathology have suggested that the development of COVID-19 to severe respiratory failure is driven by a unique pattern of immune dysregulation, with two key features: overproduction of pro-inflammatory cytokines by monocytes and dysregulation of lymphocytes, characterized by CD4 lymphopenia and subsequently B cell lymphopenia [8]. Here, CD4 is linked to respiratory failure.